Clobazam
Clobazam is a prescription benzodiazepine medication available as an oral suspension (2.5 mg/mL) for treating certain seizure disorders. It's a controlled substance (Schedule CIV) manufactured by NorthStar RxLLC under ANDA209796. This generic drug comes in a 120 mL glass bottle. This information was generated using AI and is provided for informational and research purposes only.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Clobazam is a prescription benzodiazepine medication available as an oral suspension (2.5 mg/mL) for treating certain seizure disorders. It's a controlled substance (Schedule CIV) manufactured by NorthStar RxLLC under ANDA209796. This generic drug comes in a 120 mL glass bottle. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Clobazam",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Clobazam — ANDA 209687 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209687"
}
]
|
| identifier | ANDA209687 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-manufacturers",
"fda",
"health-care",
"public-health"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Clobazam |
